Fat embolism syndrome complicating intraarterial chemotherapy with Cis-platinum

A 19-year-old man with telangiectatic osteosarcoma of the left proximal femur was started on a course of neoadjuvant chemotherapy consisting of intraarterial administration of cis-platinum. Within 72 hours of receiving the first intraarterial dose, the patient developed signs and symptoms of fat emb...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical orthopaedics and related research 1990-05, Vol.254 (254), p.294-297
Hauptverfasser: MENENDEZ, L. R, BACON, W, KEMPF, R. A, MOORE, T. M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 297
container_issue 254
container_start_page 294
container_title Clinical orthopaedics and related research
container_volume 254
creator MENENDEZ, L. R
BACON, W
KEMPF, R. A
MOORE, T. M
description A 19-year-old man with telangiectatic osteosarcoma of the left proximal femur was started on a course of neoadjuvant chemotherapy consisting of intraarterial administration of cis-platinum. Within 72 hours of receiving the first intraarterial dose, the patient developed signs and symptoms of fat embolism syndrome (FES). A physical examination revealed cyanosis, tachycardia, and seizure activity. Laboratory studies demonstrated a pO2 of less than 65 mmHg, lipuria, and a drop in hematocrit of three percentage points. There was no clinical or roentgenographic evidence of pathologic fracture. Tumor necrosis secondary to intraarterial cis-platinum therapy in this patient with osteosarcoma may have caused a sudden release of free fatty acids and embolization of fat macroglobules that precipitated this episode of FES. FES in association with the intraarterial administration of cis-platinum seems not to have been previously reported.
doi_str_mv 10.1097/00003086-199005000-00044
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00003086_199005000_00044</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2323145</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-660a0873f838f9cb16d81b419b84b428fabbbe440d6da2ad7db76fd0559fd13d3</originalsourceid><addsrcrecordid>eNo9kFtLAzEQhYMotVZ_gpAHX6O57W7yKMUbFPqi4NuSq41sdpckRfrv3dragWGYOefMwwcAJPieYNk84KkYFjUiUmJcTRuamvMzMCcVFYgQRs_BfLpJJCn5vARXOX_vQ7yiMzCjjDLCqzlYP6sCXdRDF3KEedfbNEQHzRDHLhhVQv8FQ1-SUqm4FFQHzcbFoWxcUuMO_oSygcuQ0djtvdt4DS686rK7Oc4F-Hh-el--otX65W35uEKGMVlQXWOFRcO8YMJLo0ltBdGcSC245lR4pbV2nGNbW0WVbaxuam9xVUlvCbNsAcThr0lDzsn5dkwhqrRrCW73iNp_RO0JUfuHaIreHqLjVkdnT8Ejk0m_O-oqG9X5pHoT8snGa0ka2rBftTVv7g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Fat embolism syndrome complicating intraarterial chemotherapy with Cis-platinum</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>MENENDEZ, L. R ; BACON, W ; KEMPF, R. A ; MOORE, T. M</creator><creatorcontrib>MENENDEZ, L. R ; BACON, W ; KEMPF, R. A ; MOORE, T. M</creatorcontrib><description>A 19-year-old man with telangiectatic osteosarcoma of the left proximal femur was started on a course of neoadjuvant chemotherapy consisting of intraarterial administration of cis-platinum. Within 72 hours of receiving the first intraarterial dose, the patient developed signs and symptoms of fat embolism syndrome (FES). A physical examination revealed cyanosis, tachycardia, and seizure activity. Laboratory studies demonstrated a pO2 of less than 65 mmHg, lipuria, and a drop in hematocrit of three percentage points. There was no clinical or roentgenographic evidence of pathologic fracture. Tumor necrosis secondary to intraarterial cis-platinum therapy in this patient with osteosarcoma may have caused a sudden release of free fatty acids and embolization of fat macroglobules that precipitated this episode of FES. FES in association with the intraarterial administration of cis-platinum seems not to have been previously reported.</description><identifier>ISSN: 0009-921X</identifier><identifier>EISSN: 1528-1132</identifier><identifier>DOI: 10.1097/00003086-199005000-00044</identifier><identifier>PMID: 2323145</identifier><identifier>CODEN: CORTBR</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adult ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cisplatin - administration &amp; dosage ; Cisplatin - adverse effects ; Embolism, Fat - etiology ; Femoral Neoplasms - drug therapy ; Humans ; Infusion Pumps ; Injections, Intra-Arterial ; Male ; Medical sciences ; Osteosarcoma - drug therapy ; Syndrome</subject><ispartof>Clinical orthopaedics and related research, 1990-05, Vol.254 (254), p.294-297</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-660a0873f838f9cb16d81b419b84b428fabbbe440d6da2ad7db76fd0559fd13d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4691727$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2323145$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MENENDEZ, L. R</creatorcontrib><creatorcontrib>BACON, W</creatorcontrib><creatorcontrib>KEMPF, R. A</creatorcontrib><creatorcontrib>MOORE, T. M</creatorcontrib><title>Fat embolism syndrome complicating intraarterial chemotherapy with Cis-platinum</title><title>Clinical orthopaedics and related research</title><addtitle>Clin Orthop Relat Res</addtitle><description>A 19-year-old man with telangiectatic osteosarcoma of the left proximal femur was started on a course of neoadjuvant chemotherapy consisting of intraarterial administration of cis-platinum. Within 72 hours of receiving the first intraarterial dose, the patient developed signs and symptoms of fat embolism syndrome (FES). A physical examination revealed cyanosis, tachycardia, and seizure activity. Laboratory studies demonstrated a pO2 of less than 65 mmHg, lipuria, and a drop in hematocrit of three percentage points. There was no clinical or roentgenographic evidence of pathologic fracture. Tumor necrosis secondary to intraarterial cis-platinum therapy in this patient with osteosarcoma may have caused a sudden release of free fatty acids and embolization of fat macroglobules that precipitated this episode of FES. FES in association with the intraarterial administration of cis-platinum seems not to have been previously reported.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cisplatin - administration &amp; dosage</subject><subject>Cisplatin - adverse effects</subject><subject>Embolism, Fat - etiology</subject><subject>Femoral Neoplasms - drug therapy</subject><subject>Humans</subject><subject>Infusion Pumps</subject><subject>Injections, Intra-Arterial</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Osteosarcoma - drug therapy</subject><subject>Syndrome</subject><issn>0009-921X</issn><issn>1528-1132</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kFtLAzEQhYMotVZ_gpAHX6O57W7yKMUbFPqi4NuSq41sdpckRfrv3dragWGYOefMwwcAJPieYNk84KkYFjUiUmJcTRuamvMzMCcVFYgQRs_BfLpJJCn5vARXOX_vQ7yiMzCjjDLCqzlYP6sCXdRDF3KEedfbNEQHzRDHLhhVQv8FQ1-SUqm4FFQHzcbFoWxcUuMO_oSygcuQ0djtvdt4DS686rK7Oc4F-Hh-el--otX65W35uEKGMVlQXWOFRcO8YMJLo0ltBdGcSC245lR4pbV2nGNbW0WVbaxuam9xVUlvCbNsAcThr0lDzsn5dkwhqrRrCW73iNp_RO0JUfuHaIreHqLjVkdnT8Ejk0m_O-oqG9X5pHoT8snGa0ka2rBftTVv7g</recordid><startdate>19900501</startdate><enddate>19900501</enddate><creator>MENENDEZ, L. R</creator><creator>BACON, W</creator><creator>KEMPF, R. A</creator><creator>MOORE, T. M</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19900501</creationdate><title>Fat embolism syndrome complicating intraarterial chemotherapy with Cis-platinum</title><author>MENENDEZ, L. R ; BACON, W ; KEMPF, R. A ; MOORE, T. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-660a0873f838f9cb16d81b419b84b428fabbbe440d6da2ad7db76fd0559fd13d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cisplatin - administration &amp; dosage</topic><topic>Cisplatin - adverse effects</topic><topic>Embolism, Fat - etiology</topic><topic>Femoral Neoplasms - drug therapy</topic><topic>Humans</topic><topic>Infusion Pumps</topic><topic>Injections, Intra-Arterial</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Osteosarcoma - drug therapy</topic><topic>Syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MENENDEZ, L. R</creatorcontrib><creatorcontrib>BACON, W</creatorcontrib><creatorcontrib>KEMPF, R. A</creatorcontrib><creatorcontrib>MOORE, T. M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Clinical orthopaedics and related research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MENENDEZ, L. R</au><au>BACON, W</au><au>KEMPF, R. A</au><au>MOORE, T. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fat embolism syndrome complicating intraarterial chemotherapy with Cis-platinum</atitle><jtitle>Clinical orthopaedics and related research</jtitle><addtitle>Clin Orthop Relat Res</addtitle><date>1990-05-01</date><risdate>1990</risdate><volume>254</volume><issue>254</issue><spage>294</spage><epage>297</epage><pages>294-297</pages><issn>0009-921X</issn><eissn>1528-1132</eissn><coden>CORTBR</coden><abstract>A 19-year-old man with telangiectatic osteosarcoma of the left proximal femur was started on a course of neoadjuvant chemotherapy consisting of intraarterial administration of cis-platinum. Within 72 hours of receiving the first intraarterial dose, the patient developed signs and symptoms of fat embolism syndrome (FES). A physical examination revealed cyanosis, tachycardia, and seizure activity. Laboratory studies demonstrated a pO2 of less than 65 mmHg, lipuria, and a drop in hematocrit of three percentage points. There was no clinical or roentgenographic evidence of pathologic fracture. Tumor necrosis secondary to intraarterial cis-platinum therapy in this patient with osteosarcoma may have caused a sudden release of free fatty acids and embolization of fat macroglobules that precipitated this episode of FES. FES in association with the intraarterial administration of cis-platinum seems not to have been previously reported.</abstract><cop>Heidelberg</cop><pub>Springer</pub><pmid>2323145</pmid><doi>10.1097/00003086-199005000-00044</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-921X
ispartof Clinical orthopaedics and related research, 1990-05, Vol.254 (254), p.294-297
issn 0009-921X
1528-1132
language eng
recordid cdi_crossref_primary_10_1097_00003086_199005000_00044
source MEDLINE; Journals@Ovid Complete
subjects Adult
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cisplatin - administration & dosage
Cisplatin - adverse effects
Embolism, Fat - etiology
Femoral Neoplasms - drug therapy
Humans
Infusion Pumps
Injections, Intra-Arterial
Male
Medical sciences
Osteosarcoma - drug therapy
Syndrome
title Fat embolism syndrome complicating intraarterial chemotherapy with Cis-platinum
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A38%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fat%20embolism%20syndrome%20complicating%20intraarterial%20chemotherapy%20with%20Cis-platinum&rft.jtitle=Clinical%20orthopaedics%20and%20related%20research&rft.au=MENENDEZ,%20L.%20R&rft.date=1990-05-01&rft.volume=254&rft.issue=254&rft.spage=294&rft.epage=297&rft.pages=294-297&rft.issn=0009-921X&rft.eissn=1528-1132&rft.coden=CORTBR&rft_id=info:doi/10.1097/00003086-199005000-00044&rft_dat=%3Cpubmed_cross%3E2323145%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2323145&rfr_iscdi=true